These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29052453)

  • 1. Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.
    Krooks JA; Weatherall AG; Holland PJ
    J Dermatolog Treat; 2018 Jun; 29(4):418-427. PubMed ID: 29052453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychocutaneous disease: Clinical perspectives.
    Kuhn H; Mennella C; Magid M; Stamu-O'Brien C; Kroumpouzos G
    J Am Acad Dermatol; 2017 May; 76(5):779-791. PubMed ID: 28411771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable clinical presentations of secondary delusional infestation: an experience of six cases from a psychodermatology clinic.
    Altunay IK; Ates B; Mercan S; Demirci GT; Kayaoglu S
    Int J Psychiatry Med; 2012; 44(4):335-50. PubMed ID: 23885516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antipsychotic drugs in dermatology.
    Gupta MA; Vujcic B; Pur DR; Gupta AK
    Clin Dermatol; 2018; 36(6):765-773. PubMed ID: 30446201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychodermatology.
    Brown GE; Malakouti M; Sorenson E; Gupta R; Koo JY
    Adv Psychosom Med; 2015; 34():123-34. PubMed ID: 25832518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body dysmorphic disorder.
    Fang A; Matheny NL; Wilhelm S
    Psychiatr Clin North Am; 2014 Sep; 37(3):287-300. PubMed ID: 25150563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delusional disorder-somatic type (or body dysmorphic disorder) and schizophrenia: a case report.
    Issa BA
    Afr J Psychiatry (Johannesbg); 2010 Mar; 13(1):61-3. PubMed ID: 20454749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments.
    Dong N; Nezgovorova V; Hong K; Hollander E
    Expert Opin Pharmacother; 2019 Jul; 20(10):1211-1219. PubMed ID: 31038370
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 11. Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments.
    Ravindran AV; da Silva TL; Ravindran LN; Richter MA; Rector NA
    Can J Psychiatry; 2009 May; 54(5):331-43. PubMed ID: 19497165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive-compulsive skin disorders: a novel classification based on degree of insight.
    Zhu TH; Nakamura M; Farahnik B; Abrouk M; Reichenberg J; Bhutani T; Koo J
    J Dermatolog Treat; 2017 Jun; 28(4):342-346. PubMed ID: 27658538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of antidepressant drugs in dermatology.
    Gupta MA; Guptat AK
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):512-8. PubMed ID: 11843209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.
    Kim D; Ryba NL; Kalabalik J; Westrich L
    Drugs R D; 2018 Sep; 18(3):167-189. PubMed ID: 30171515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in understanding and managing body dysmorphic disorder.
    Krebs G; Fernández de la Cruz L; Mataix-Cols D
    Evid Based Ment Health; 2017 Aug; 20(3):71-75. PubMed ID: 28729345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morgellons disease etiology and therapeutic approach: a systematic review.
    Beuerlein KG; Balogh EA; Feldman SR
    Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin-Picking Disorder: A Guide to Diagnosis and Management.
    Jafferany M; Patel A
    CNS Drugs; 2019 Apr; 33(4):337-346. PubMed ID: 30877621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Treatment of Body Dysmorphic Disorder.
    Hong K; Nezgovorova V; Uzunova G; Schlussel D; Hollander E
    Curr Neuropharmacol; 2019; 17(8):697-702. PubMed ID: 29701157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
    Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG
    J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.